Lab22
ActiveSummary
The computed 12-month bankruptcy probability of Lab22 is at least 25% (high). The 2024 annual accounts show equity of €0 and a net result of -€1,394. The company has been active since 2023 and the Belgian Official Gazette contains no insolvency signals. The KBO does carry 1 administrative register entry (see administrative flags).
Financials · financial year 2024, micro format
2024 annual accounts filed late (50 days) Filed on 19 September 2025, deadline 31 July 2025 (7 months after the close on 31 December 2024, Companies Code art. 3:10). Source: NBB, 2025-00508099.
Turnover and EBIT margin not published: the micro format does not require them.
| Line | 2024 |
|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €1,174 |
| Other operating charges640/8 | €220 |
| Operating profit (loss)9901 | -€1,394 |
| Profit (loss) for the period before taxes9903 | -€1,394 |
| Profit (loss) for the period9904 | -€1,394 |
| Profit (loss) for the period to be appropriated9905 | -€1,394 |
| Line | 2024 | |
|---|---|---|
| Equity and liabilities | ||
| Total equity and liabilities10/49 | €0 | |
| Equity10/15 | €0 | |
| Contributions10/11 | €1,394 | |
| Profit (loss) carried forward14 | -€1,394 | |
| Line | 2024 |
|---|---|
| Profit (loss) for the period9904 | -€1,394 |
| + Depreciation and write-downs630 | €1,174 |
| Operating cash flow (approximation) | -€220 |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (1)
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | micro format | 19-09-2025 | 2025-00508099 |
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.